乙肝患者-话题@MedSci - 梅斯（MedSci）

#乙肝患者#

55篇内容 | 1933人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1671744, encodeId=c2ab16e174406, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=APT：ALT正常的慢乙肝患者肝纤维化比例仍较高, objectType=article, longId=31149, objectId=a23831149ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a23831149ec, replyNumber=0, likeNumber=68, createdTime=2014-11-22, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a23831149ec, moduleTitle=APT：ALT正常的慢乙肝患者肝纤维化比例仍较高, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a23831149ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671747, encodeId=b8eb16e17474a, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=Gut：恩替卡韦不能消除乙肝患者的肝细胞癌风险, objectType=article, longId=38159, objectId=45a73815926, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=45a73815926, replyNumber=0, likeNumber=74, createdTime=2015-03-26, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=45a73815926, moduleTitle=Gut：恩替卡韦不能消除乙肝患者的肝细胞癌风险, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=45a73815926)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671745, encodeId=78e816e1745a0, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=Clin Gastroenterol Hepatol：抗病毒或降乙肝患者肝癌风险, objectType=article, longId=36550, objectId=d6df36550fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d6df36550fe, replyNumber=0, likeNumber=93, createdTime=2014-09-06, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d6df36550fe, moduleTitle=Clin Gastroenterol Hepatol：抗病毒或降乙肝患者肝癌风险, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d6df36550fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671742, encodeId=4c4a16e174229, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=Hepatology：香港中文大学Vincent WS Wong等发现AFP为诊断恩替卡韦治疗慢乙肝患者发生肝癌的特异性肿瘤标记物, objectType=article, longId=26581, objectId=4fb426581aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4fb426581aa, replyNumber=0, likeNumber=70, createdTime=2014-07-17, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4fb426581aa, moduleTitle=Hepatology：香港中文大学Vincent WS Wong等发现AFP为诊断恩替卡韦治疗慢乙肝患者发生肝癌的特异性肿瘤标记物, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4fb426581aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671746, encodeId=613b16e17462a, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=Gastroenterology：预防慢性乙肝患者肝癌的治疗方法, objectType=article, longId=37239, objectId=98233e239f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=98233e239f8, replyNumber=0, likeNumber=79, createdTime=2014-12-10, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=98233e239f8, moduleTitle=Gastroenterology：预防慢性乙肝患者肝癌的治疗方法, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=98233e239f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671740, encodeId=873e16e1740c1, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=Hepatology：长期富马酸替诺福韦酯治疗可使高病毒载量的慢性乙肝患者HBV DNA转阴, objectType=article, longId=24197, objectId=75e82419eae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75e82419eae, replyNumber=0, likeNumber=64, createdTime=2014-03-21, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75e82419eae, moduleTitle=Hepatology：长期富马酸替诺福韦酯治疗可使高病毒载量的慢性乙肝患者HBV DNA转阴, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=75e82419eae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671743, encodeId=344a16e1743f4, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=Gut：Besifovir或可成为慢乙肝患者治疗新选择, objectType=article, longId=28745, objectId=b67828e451c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b67828e451c, replyNumber=0, likeNumber=88, createdTime=2014-04-03, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b67828e451c, moduleTitle=Gut：Besifovir或可成为慢乙肝患者治疗新选择, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b67828e451c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671733, encodeId=bab416e173316, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=J HEPATOL：慢性乙肝患者血清spHBV水平或可预测肝细胞癌风险, objectType=article, longId=21053, objectId=529921053f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=529921053f1, replyNumber=0, likeNumber=81, createdTime=2013-09-19, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=529921053f1, moduleTitle=J HEPATOL：慢性乙肝患者血清spHBV水平或可预测肝细胞癌风险, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=529921053f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671734, encodeId=50df16e173491, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=恩替卡韦部分应答及耐药慢乙肝患者联合ADV治疗1例, objectType=article, longId=21378, objectId=f746213e822, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f746213e822, replyNumber=0, likeNumber=90, createdTime=2013-12-14, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f746213e822, moduleTitle=恩替卡韦部分应答及耐药慢乙肝患者联合ADV治疗1例, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f746213e822)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671741, encodeId=d93216e1741a8, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=J Hepatol：LSM-HCC评分可准确预测慢乙肝患者肝癌发生风险, objectType=article, longId=25617, objectId=36472561e7d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36472561e7d, replyNumber=0, likeNumber=71, createdTime=2014-05-05, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36472561e7d, moduleTitle=J Hepatol：LSM-HCC评分可准确预测慢乙肝患者肝癌发生风险, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=36472561e7d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671737, encodeId=bd8e16e173754, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=慢性乙肝患者长期核苷（酸）药物抗病毒疗效观察, objectType=article, longId=22495, objectId=47c32249590, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47c32249590, replyNumber=0, likeNumber=73, createdTime=2013-11-13, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47c32249590, moduleTitle=慢性乙肝患者长期核苷（酸）药物抗病毒疗效观察, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=47c32249590)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671736, encodeId=dcdf16e1736b6, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=我国乙肝患者疾病认知令人忧, objectType=article, longId=21992, objectId=29ce2199259, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29ce2199259, replyNumber=0, likeNumber=75, createdTime=2014-05-15, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29ce2199259, moduleTitle=我国乙肝患者疾病认知令人忧, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=29ce2199259)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671739, encodeId=31ed16e17395c, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=Journal of Hepatology：基因型特异性HBsAg动力学可指导HBeAg(-)慢性乙肝患者的治疗, objectType=article, longId=22616, objectId=ec01226163e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec01226163e, replyNumber=0, likeNumber=96, createdTime=2013-11-24, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec01226163e, moduleTitle=Journal of Hepatology：基因型特异性HBsAg动力学可指导HBeAg(-)慢性乙肝患者的治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ec01226163e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671735, encodeId=cbcb16e173579, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=Hepatology：HBeAg阴性慢乙肝患者应用ETV停药标准, objectType=article, longId=21388, objectId=c01b2138812, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c01b2138812, replyNumber=0, likeNumber=65, createdTime=2014-01-10, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c01b2138812, moduleTitle=Hepatology：HBeAg阴性慢乙肝患者应用ETV停药标准, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c01b2138812)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671738, encodeId=a24f16e1738be, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=慢性乙肝患者长期核苷（酸）药物抗病毒疗效观察, objectType=article, longId=22612, objectId=4a702261287, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a702261287, replyNumber=0, likeNumber=73, createdTime=2013-08-23, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a702261287, moduleTitle=慢性乙肝患者长期核苷（酸）药物抗病毒疗效观察, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4a702261287)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

乙肝患者

2020-05-29

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

APT：ALT正常的慢乙肝患者肝纤维化比例仍较高

2014-11-22

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

Gut：恩替卡韦不能消除乙肝患者的肝细胞癌风险

2015-03-26

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

Clin Gastroenterol Hepatol：抗病毒或降乙肝患者肝癌风险

2014-09-06

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

Hepatology：香港中文大学Vincent WS Wong等发现AFP为诊断恩替卡韦治疗慢乙肝患者发生肝癌的特异性肿瘤标记物

2014-07-17

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

Gastroenterology：预防慢性乙肝患者肝癌的治疗方法

2014-12-10

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

Hepatology：长期富马酸替诺福韦酯治疗可使高病毒载量的慢性乙肝患者HBV DNA转阴

2014-03-21

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

Gut：Besifovir或可成为慢乙肝患者治疗新选择

2014-04-03

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

J HEPATOL：慢性乙肝患者血清spHBV水平或可预测肝细胞癌风险

2013-09-19

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

恩替卡韦部分应答及耐药慢乙肝患者联合ADV治疗1例

2013-12-14

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

J Hepatol：LSM-HCC评分可准确预测慢乙肝患者肝癌发生风险

2014-05-05

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

慢性乙肝患者长期核苷（酸）药物抗病毒疗效观察

2013-11-13

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

我国乙肝患者疾病认知令人忧

2014-05-15

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

Journal of Hepatology：基因型特异性HBsAg动力学可指导HBeAg(-)慢性乙肝患者的治疗

2013-11-24

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

Hepatology：HBeAg阴性慢乙肝患者应用ETV停药标准

2014-01-10

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

慢性乙肝患者长期核苷（酸）药物抗病毒疗效观察

2013-08-23

科室
- - 订阅+
  - 更多科室
工具
服务